Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
---|
06/25/1997 | CN1152874A Copolymer-1 improvements in compositions of copolymers |
06/25/1997 | CN1152866A Soap composition |
06/25/1997 | CN1152468A Slow releasing composition |
06/24/1997 | US5641805 Topical ophthalmic formulations for treating allergic eye diseases |
06/24/1997 | US5641517 Composition comprising fertilized shell eggs |
06/24/1997 | US5641477 Consists of hydrogenated starch hydrolyzate and/or sugar |
06/24/1997 | US5641471 Method for preparing 213 Bi for therapeutic use |
06/18/1997 | EP0778766A1 Topically-effective compositions |
06/18/1997 | CN1035180C Prep. of Macrolide antibiotics |
06/17/1997 | US5639463 Clear cosmetic stick composition |
06/12/1997 | WO1997020815A1 Compounds |
06/12/1997 | WO1997020564A1 Targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags) |
06/11/1997 | EP0778025A1 Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of diseases caused by free radicals |
06/11/1997 | EP0654991B1 Inhalation powder containing antistatic agent |
06/11/1997 | CN1151699A Health compsn. |
06/11/1997 | CN1151697A Anti-hiv triple combination |
06/11/1997 | CN1151696A 抗菌剂 Antibacterial agents |
06/10/1997 | US5637572 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis |
06/05/1997 | WO1997019668A2 Toothpaste and mouthwash in tablets |
06/05/1997 | WO1996039113A3 Oral administration of pneumococcal antigens |
06/05/1997 | CA2191835A1 Use of 8,9-dehydroestrone as an antioxidant |
06/04/1997 | EP0776219A2 Compositions |
06/04/1997 | CN1151164A Sterol derivatives used for regulation of meiosis |
06/03/1997 | USRE35524 Antitumor agents |
06/03/1997 | US5635187 Adding phytogenic compounds to storage solution to increase organ preservation for transplantation |
06/03/1997 | US5635186 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
06/03/1997 | US5635185 Extracts of Piliostigma thonningii, the use thereof and formulations containing them |
06/03/1997 | US5635164 Stick composition with sodium chloride and stearyl alcohol |
06/03/1997 | CA2143204C Use of dideoxy nucleoside analogues in the treatment of viral infections |
06/03/1997 | CA2098199C Psyllium and cholestyramine compositions with improved palatability |
06/03/1997 | CA2067888C Cosmetic composition |
05/29/1997 | WO1997018841A1 Non-invasive localization of a light-emitting conjugate in a mammal |
05/29/1997 | WO1997018833A1 Methods of increasing lean tissue mass using ob protein compositions |
05/29/1997 | CA2358862A1 Methods of increasing lean tissue mass using ob protein compositions |
05/29/1997 | CA2236163A1 Methods of increasing lean tissue mass using ob protein compositions |
05/28/1997 | EP0775482A2 Cosmetic compositions containing tricholine citrate |
05/28/1997 | EP0774969A1 Hiv protease inhibitor combination |
05/28/1997 | EP0671918B1 Compositions containing acyclovir-like compounds and 2'-vinyl substituted nucleoside analogs for the treatment of viral infections |
05/27/1997 | US5633241 Administering as antileukemia agent |
05/21/1997 | CN1150435A Process for removing bile salt from patient and alkylated compositions therefor |
05/20/1997 | US5631245 Di-beta-glycopyranosylamine from glucose and nitrogen base |
05/20/1997 | US5631241 Wound healing agents of high molecular weight for eyes as antiinflammatory agents |
05/20/1997 | US5630999 Oral composition containing anionic surfactants having reduced adverse reaction to oral tissue |
05/15/1997 | WO1997017343A1 Indolealkyl derivatives of benzodioxanmethylamine as 5-ht1a receptor ligands |
05/15/1997 | CA2236678A1 Indolealkyl derivatives of benzodioxanmethylamine as 5-ht1a receptor ligands |
05/14/1997 | EP0772447A1 Chinese herbs extract |
05/14/1997 | EP0772446A1 Anti-adhesion agent |
05/14/1997 | EP0772444A1 Use of the enantiomers of oxazophosphorines, e.g. ifosfamide, in anti-tumour therapy, for reducing side-effects |
05/14/1997 | CN1149831A Controlled-release dosage forms of azithromycin |
05/14/1997 | CN1149830A Pyridylbisphosphonates for use as therapeutical agent |
05/13/1997 | US5629315 Treatment of psoriasis, asthma,osteoporosis, alcoholic hepatitis, and premature labor |
05/13/1997 | US5629303 Controlled release systems and low dose androgens |
05/09/1997 | WO1997016439A1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
05/09/1997 | WO1997016197A1 Extracts of shark cartilage |
05/09/1997 | WO1997016193A1 Pharmaceutical composition for treating osteoporosis |
05/09/1997 | WO1997016162A1 Underarm compositions |
05/09/1997 | WO1997016161A1 Underarm compositions |
05/07/1997 | EP0771789A1 1 alpha, 26-dihydroxy-D-homo-vitamin D3 |
05/07/1997 | EP0771202A1 USE OF (S)-ADENOSYL-L-METHIONINE (SAMe) AND ITS PHYSIOLOGICALLY COMPATIBLE SALTS FOR TREATING REPERFUSION DAMAGE TRIGGERED BY TEMPORARY FOCAL ISCHAEMIA |
05/07/1997 | EP0771188A2 Soap composition |
05/07/1997 | EP0621870B1 A human kunitz-type protease inhibitor variant |
05/07/1997 | EP0602050B1 Method of stimulating immune response |
05/07/1997 | CN1149251A Combined two-part reducing agent/humectant shaving system for inproved shaving comfort |
05/07/1997 | CN1149250A Improved anti-dandruff shampoo |
05/06/1997 | US5627186 Treatment of htlv or aids with 4-amino-1-(2-hydroxymethyl oxathiolan-5-yl)-1h-pyrimidin-2-one with 3'-azido-3'-deoxy thymidine |
05/06/1997 | US5626852 Composition containing body activated fragrance for contacting the skin and method of use |
05/02/1997 | EP0769965A1 Aqueous risperidone formulations |
05/01/1997 | WO1997015280A1 Use of at least one no synthase inhibitor for treating sensitive skin |
05/01/1997 | CA2188634A1 1ó,26 dihydroxy-d-homo-vitamin d3 |
04/30/1997 | CN1148855A Novel spiro [indole-pyrrolidine]derivatives as melatoninergic agonists, method for preparing same and use thereof as drug |
04/30/1997 | CN1148849A Process for preparing anhydrous and hydrate forms of antihistaminic pipeeridine derivatives, polymorphs and spseudormophs thereof |
04/30/1997 | CN1148596A Noval crystal type anhydrous 7-([1 alpha, 5 alpha, 6 alpha]-6-amino-3-azabicyclo[3,1,0]hexyl-3-group)-6-fluorine-1-(2,4-difluorophenyl |
04/29/1997 | US5624672 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
04/24/1997 | WO1997014686A1 Pharmaceutically active quinazoline compounds |
04/24/1997 | WO1997014397A1 A depilatory composition with improved rinsing properties |
04/24/1997 | CA2235304A1 Pharmaceutically active quinazoline compounds |
04/23/1997 | EP0768884A1 Drugs containing metronidazole or a synergistic mixture of metronidazole and clindamycin |
04/23/1997 | EP0768881A2 Anti-hiv triple combination |
04/23/1997 | EP0768872A1 New oral pharmaceutical formulation containing magnesium salt of omeprazole |
04/23/1997 | CN1148344A New oral pharmaceutical dosage form |
04/23/1997 | CN1147961A Stable liquid composition containing urate oxidase and lyophilized composition for its prepn. |
04/23/1997 | CN1034631C Process for producing new agent having antiphlogistic activity |
04/22/1997 | US5622952 Glycine receptor antagonists and the use thereof |
04/17/1997 | WO1997013495A1 Antimicrobial compositions containing a c3-c6 alcohol |
04/17/1997 | WO1997013492A2 Strengthening agent |
04/17/1997 | CA2232640A1 Antimicrobial compositions containing a c3-c6 alcohol |
04/16/1997 | EP0768089A1 Health composition |
04/16/1997 | EP0768085A1 Antibacterial agent |
04/16/1997 | EP0767798A1 Sterol derivatives used for regulation of meiosis |
04/16/1997 | EP0767664A2 Combination therapy for hiv infection |
04/16/1997 | EP0502180B1 Enzymatic synthesis of oligonucleotides |
04/16/1997 | CN1147765A Remedy for pulmonary heart |
04/16/1997 | CN1147520A 11-(substituted phenyl)-estra-4,9-diene derivatives |
04/16/1997 | CN1147516A Bioavailable crystalline form of cefuroxime axetil |
04/16/1997 | CN1034553C Avirulent microbes and uses therefor |
04/15/1997 | US5621102 Reacting pinanediol chiral director and haloalkyl dialkoxy metalloid compound to undergo homologation reaction to form intermediate, reacting it with grignard reagent to form secondary alchol, acylating, coupling side chain |
04/15/1997 | US5620984 Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases |
04/15/1997 | US5620979 Treating neuronal loss associated with stroke, ischemia, central nervous system trauma, hypoglycemia or surgery |
04/15/1997 | US5620885 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
04/15/1997 | US5620697 Mixing biodegradable polymer and solid drug, exposure to ultrasonic frequency vibrations for melting, then cooling yields sustained release composite for drug delivery |